Agenus to Participate in Upcoming September Investor Conferences
Business Wire•31/08/2026•07:30 ET
0
Whiz Insights
Agenus to Participate in Upcoming September Investor Conferences
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that Robin Taylor, Ph.D., Chief Commercial Officer, and Zack Armen, Head of Corporate Development and Investor Relations, will participate in fireside chats and one-on-one investor meetings at two upcoming investor conferences in September.
Get started
Create a free account to read the full story.